Kwang Dong Pharmaceutical Co., Ltd. (009290.KS)
KRW 5670.0
(0.0%)
KRW 5670.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -11.73 Billion | 62.82 Billion | 54.93 Billion | 22.82 Billion | 29.28 Billion | 53.09 Billion |
| Net Income | 36.96 Billion | 26.7 Billion | 25.54 Billion | 45.6 Billion | 22.65 Billion | 21.97 Billion |
| Depreciation & Amortization | 12.83 Billion | 14.01 Billion | 14.1 Billion | 19.7 Billion | 18.8 Billion | 17.45 Billion |
| Deferred income taxes | - | - | 17.76 Billion | 967.47 Million | 15.35 Billion | - |
| Stock-based compensation | - | - | 17.58 Million | 152.06 Million | 212.06 Million | - |
| Change in working capital | -69.2 Billion | 6.21 Billion | -3.89 Billion | -44.35 Billion | -29.03 Billion | 6.13 Billion |
| Other non-cash items | 7.66 Billion | 15.88 Billion | 1.4 Billion | 752.51 Million | 1.29 Billion | 7.53 Billion |
| Investing Cash Flow | -70.82 Billion | -42.74 Billion | -42.97 Billion | -47.56 Billion | -17.78 Billion | -20.36 Billion |
| Investments in PPE | -35.15 Billion | -26.03 Billion | -24.44 Billion | -5.3 Billion | -12.68 Billion | -19.14 Billion |
| Acquisitions | -21.21 Billion | -2.89 Billion | -2.26 Billion | -1.27 Billion | -287.03 Million | -1.89 Billion |
| Investment purchases | -630.92 Billion | -708.64 Billion | -505.58 Billion | -336.2 Billion | -209.65 Billion | -379.79 Billion |
| Sales/Maturities of investments | 616.34 Billion | 693.64 Billion | 488.85 Billion | 270.4 Billion | 203.99 Billion | 371.51 Billion |
| Other Investing Activities | 133.23 Million | 1.18 Billion | 463.62 Million | 24.8 Billion | 838.52 Million | 8.95 Billion |
| Financing Cash Flow | 57 Billion | -628.25 Million | 15.89 Billion | 3.83 Billion | -3.2 Billion | -13.08 Billion |
| Debt repayment | -69 Billion | -114 Billion | -116 Billion | -106.83 Billion | -165.13 Billion | -142.84 Billion |
| Dividends payments | -4.1 Billion | -4.1 Billion | -4.1 Billion | -3.16 Billion | -3.21 Billion | -3.24 Billion |
| Common Stock Repurchased | -6.23 Billion | - | 85.54 Million | - | -4.31 Billion | -2.78 Billion |
| Common Stock Issuance | -2.66 Billion | - | -85.54 Million | 9.52 Billion | 169.68 Billion | 134.2 Billion |
| Other Financing Activities | 139 Billion | 117.47 Billion | 136 Billion | 104.31 Billion | -223.51 Million | 1.59 Billion |
| Accounts receivables | -23.15 Billion | 17.54 Billion | -15.92 Billion | 11.85 Billion | -15.42 Billion | 14.84 Billion |
| Accounts payables | -7.21 Billion | 20.5 Billion | -2.98 Billion | -2.94 Billion | 15.61 Billion | 3.03 Billion |
| Inventory | -33.19 Billion | -16.56 Billion | 15.15 Billion | -31.27 Billion | -37.18 Billion | -6.65 Billion |
| Other working capital | -5.63 Billion | -15.25 Billion | -141.37 Million | -21.98 Billion | 7.95 Billion | 12.79 Billion |
| Cash at beginning of period | 103.55 Billion | 83.96 Billion | 54.88 Billion | 76.28 Billion | 67.48 Billion | 47.6 Billion |
| Cash at end of period | 77.34 Billion | 103.55 Billion | 83.96 Billion | 54.88 Billion | 76.28 Billion | 67.48 Billion |
| Capital Expenditure | -35.15 Billion | -26.03 Billion | -24.44 Billion | -5.3 Billion | -12.68 Billion | -19.14 Billion |
| Effect of forex changes on cash | -656.99 Million | 139.35 Million | 1.22 Billion | -504.96 Million | 507.67 Million | 228.91 Million |
| Net cash flow / Change in cash | -26.2 Billion | 19.58 Billion | 29.08 Billion | -21.39 Billion | 8.79 Billion | 19.88 Billion |
| Free Cash Flow | -46.88 Billion | 36.78 Billion | 30.49 Billion | 17.52 Billion | 16.6 Billion | 33.95 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.32 Billion | 18.2 Billion | 5.53 Billion | 36.96 Billion | 9.31 Billion | 9 Billion |
| Depreciation & Amortization | 3.43 Billion | 3.81 Billion | 2.9 Billion | 12.83 Billion | 3.61 Billion | 3.14 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -16.8 Billion | -38.38 Billion | -22.69 Billion | -69.2 Billion | -26.57 Billion | 3.65 Billion |
| Other non-cash items | 1.93 Billion | 27.54 Billion | 5.26 Billion | 7.66 Billion | -2 Billion | -1.04 Billion |
| Investing Cash Flow | -17.2 Billion | 8.73 Billion | -19.74 Billion | -70.82 Billion | 37.85 Billion | -73.36 Billion |
| Investments in PPE | -19.99 Billion | -8.2 Billion | -12.62 Billion | -35.15 Billion | -8.98 Billion | -8.48 Billion |
| Acquisitions | 2.33 Million | 174 Million | -22.74 Billion | -21.21 Billion | 1.61 Billion | 135.19 Million |
| Investment purchases | -32.69 Billion | -71.04 Billion | -156.85 Billion | -630.92 Billion | -105.73 Billion | -260.91 Billion |
| Sales/Maturities of investments | 37.09 Billion | 87.59 Billion | 172.41 Billion | 616.34 Billion | 150.66 Billion | 195.77 Billion |
| Other Investing Activities | 2.79 Billion | 220.57 Million | 52.87 Million | 133.23 Million | 291.63 Million | 127.45 Million |
| Financing Cash Flow | 20.7 Billion | 13.94 Billion | 14.57 Billion | 57 Billion | -106.26 Million | 9.84 Billion |
| Debt repayment | -22.74 Billion | -14.44 Billion | -15 Billion | -69 Billion | -100 Billion | -60 Billion |
| Dividends payments | -4 Billion | - | - | -4.1 Billion | - | -4.1 Billion |
| Common Stock Repurchased | - | - | - | -6.23 Billion | - | -6.23 Billion |
| Common Stock Issuance | - | - | - | -2.66 Billion | - | 10.34 Billion |
| Other Financing Activities | 47.44 Billion | 14.44 Billion | 29.57 Billion | 139 Billion | 99.89 Billion | 69.84 Billion |
| Accounts receivables | -4.41 Billion | -13.81 Billion | 2.78 Billion | -23.15 Billion | -37.14 Billion | -2.67 Billion |
| Accounts payables | 491.54 Million | 1.14 Billion | -12.46 Billion | -7.21 Billion | 17.85 Billion | 5.72 Billion |
| Inventory | -19.64 Billion | -11.79 Billion | -11.21 Billion | -33.19 Billion | -10.11 Billion | -3.18 Billion |
| Other working capital | 7.25 Billion | -13.91 Billion | -1.81 Billion | -5.63 Billion | 2.83 Billion | 3.79 Billion |
| Cash at beginning of period | 78.86 Billion | 77.34 Billion | 91.47 Billion | 103.55 Billion | 69.42 Billion | 119.47 Billion |
| Cash at end of period | 71.87 Billion | 78.86 Billion | 77.34 Billion | 77.34 Billion | 91.47 Billion | 69.42 Billion |
| Capital Expenditure | -19.99 Billion | -8.2 Billion | -12.62 Billion | -35.15 Billion | -8.98 Billion | -8.48 Billion |
| Effect of forex changes on cash | -374.6 Million | -243.32 Million | 27.24 Million | -656.99 Million | -62.76 Million | -1.3 Billion |
| Net cash flow / Change in cash | -6.98 Billion | 1.52 Billion | -14.13 Billion | -26.2 Billion | 22.05 Billion | -50.05 Billion |
| Free Cash Flow | -30.1 Billion | -29.12 Billion | -21.6 Billion | -46.88 Billion | -24.61 Billion | 6.28 Billion |
4167
PKCOF
216050
008730
PXMFF
000050